NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free PIII Stock Alerts $0.50 -0.01 (-2.48%) (As of 04:00 PM ET) Add Compare Share Share Today's Range$0.48▼$0.5350-Day Range$0.47▼$1.1652-Week Range$0.45▼$5.56Volume808,738 shsAverage Volume375,345 shsMarket Capitalization$158.04 millionP/E RatioN/ADividend YieldN/APrice Target$4.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get P3 Health Partners alerts: Email Address P3 Health Partners MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside849.2% Upside$4.75 Price TargetShort InterestBearish4.48% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.56) to ($0.49) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.90 out of 5 starsMedical Sector800th out of 909 stocksHealth Services Industry8th out of 10 stocks 3.3 Analyst's Opinion Consensus RatingP3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageP3 Health Partners has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.48% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in P3 Health Partners has recently increased by 4.39%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PIII. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for P3 Health Partners this week, compared to 1 article on an average week.Search InterestOnly 4 people have searched for PIII on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows5 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have not sold or bought any company stock.Percentage Held by Insiders17.06% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.75% of the stock of P3 Health Partners is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for P3 Health Partners are expected to grow in the coming year, from ($0.56) to ($0.49) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is -0.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 1.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About P3 Health Partners Stock (NASDAQ:PIII)P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.Read More PIII Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PIII Stock News HeadlinesApril 19, 2024 | americanbankingnews.comCareRx (OTCMKTS:CHHHF) versus P3 Health Partners (NASDAQ:PIII) Financial SurveyApril 3, 2024 | businesswire.comP3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare ConferenceApril 24, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.March 28, 2024 | benzinga.comP3 Health Partners: Q4 Earnings InsightsMarch 28, 2024 | finance.yahoo.comP3 Health Partners Inc. Reports Revenue Growth and Affirms 2024 Guidance, Despite Net LossMarch 28, 2024 | businesswire.comP3 Health Partners Announces Fourth Quarter and Full Year 2023 ResultsMarch 17, 2024 | uk.investing.comP3 Health to report Q4 and full year 2023 earnings on March 28February 28, 2024 | businesswire.comP3 Health Partners to Participate in the Jefferies Value Based Healthcare SummitApril 24, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.February 19, 2024 | businesswire.comP3 Health Partners to Present at the TD Cowen 44th Annual Healthcare ConferenceJanuary 30, 2024 | finance.yahoo.comP3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceJanuary 19, 2024 | finance.yahoo.comP3 Health Partners Inc.'s (NASDAQ:PIII) Path To ProfitabilityJanuary 10, 2024 | msn.comP3 Health Partners reaffirms 2023 guidance, sees 2024 revenue above estimatesJanuary 10, 2024 | markets.businessinsider.comWhy Health Management Company P3 Health Partners Shares Are Up TodayJanuary 9, 2024 | markets.businessinsider.comP3 Health Partners Reaffirms 2023 Guidance, Sees 2024 Revenue Above View; Stock UpJanuary 9, 2024 | finance.yahoo.comP3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024January 2, 2024 | finance.yahoo.comP3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2023 | morningstar.comP3 Health Partners Inc Class A PIIINovember 15, 2023 | markets.businessinsider.comPositive Revenue Prospects and Improved Cash Flow: Reasons Behind David Larsen’s Buy Rating for P3 Health PartnersNovember 12, 2023 | finance.yahoo.comP3 Health Partners Inc. (NASDAQ:PIII) Q3 2023 Earnings Call TranscriptNovember 8, 2023 | businesswire.com55,508November 8, 2023 | finance.yahoo.comP3 Health Partners Announces Third-Quarter and Year-to-Date 2023 ResultsNovember 3, 2023 | finance.yahoo.comP3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference CallOctober 29, 2023 | finance.yahoo.comSeveral Insiders Invested In P3 Health Partners Flagging Positive NewsOctober 20, 2023 | money.usnews.comP3 Health Partners Inc - Ordinary Shares - Class AOctober 6, 2023 | uk.investing.comP3 Health Partners Recent Insider ActivityOctober 4, 2023 | benzinga.comP3 Health Partners 10% Owner Trades $186K In Company StockSee More Headlines Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today4/24/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:PIII CUSIPN/A CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees400Year FoundedN/APrice Target and Rating Average Stock Price Target$4.75 High Stock Price Target$5.00 Low Stock Price Target$4.50 Potential Upside/Downside+849.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-57,770,000.00 Net Margins-4.56% Pretax Margin-14.51% Return on Equity-120.85% Return on Assets-6.54% Debt Debt-to-Equity Ratio0.76 Current Ratio0.55 Quick Ratio0.55 Sales & Book Value Annual Sales$1.27 billion Price / Sales0.12 Cash Flow$0.09 per share Price / Cash Flow5.55 Book Value$0.45 per share Price / Book1.11Miscellaneous Outstanding Shares315,900,000Free Float262,010,000Market Cap$158.04 million OptionableNot Optionable Beta1.04 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Sherif Abdou F.A.C.E.P. (Age 63)FACP, M.D., Co-Founder, CEO & Director Comp: $7.1MDr. Amir Bacchus M.B.A. (Age 59)M.D., Co-Founder, Chief Medical Officer & Director Comp: $4.3MMr. Atul KavthekarCFO & Chief Accounting OfficerMr. William BettermannExecutive VP & COOMr. Devery GoodeySenior Vice President of TechnologyRoy YoungbloodDirector of ComplianceLeslie FisherSenior VP of Legal Affairs & General CounselMs. Kassi Belz APRExecutive Vice President of Communications, Culture & EngagementMr. Todd Lefkowitz MHAChief Managed Care OfficerMs. Sarah Bussmann B.S.N.CRNI, M.H.A., R.N., Chief of StaffMore ExecutivesKey CompetitorsGlobal Consumer AcquisitionNASDAQ:GACQInternational Media AcquisitionNASDAQ:IMAQFrontier InvestmentNASDAQ:FICVbleuacaciaNASDAQ:BLEUChain Bridge INASDAQ:CBRGView All CompetitorsInsiders & InstitutionsWelch Capital Partners LLC NYBought 30,000 shares on 2/5/2024Ownership: 0.010%SlateStone Wealth LLCBought 28,033 shares on 2/1/2024Ownership: 0.009%Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/13/2023Total: $238,500.00 ($2.65/share)Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/11/2023Total: $210,600.00 ($2.34/share)Pacific Founders Ugp I ChicagoBought 90,000 shares on 9/7/2023Total: $185,400.00 ($2.06/share)View All Insider TransactionsView All Institutional Transactions PIII Stock Analysis - Frequently Asked Questions Should I buy or sell P3 Health Partners stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PIII shares. View PIII analyst ratings or view top-rated stocks. What is P3 Health Partners' stock price target for 2024? 4 equities research analysts have issued twelve-month target prices for P3 Health Partners' shares. Their PIII share price targets range from $4.50 to $5.00. On average, they expect the company's stock price to reach $4.75 in the next twelve months. This suggests a possible upside of 849.2% from the stock's current price. View analysts price targets for PIII or view top-rated stocks among Wall Street analysts. How have PIII shares performed in 2024? P3 Health Partners' stock was trading at $1.41 on January 1st, 2024. Since then, PIII shares have decreased by 64.5% and is now trading at $0.5004. View the best growth stocks for 2024 here. When is P3 Health Partners' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our PIII earnings forecast. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) issued its earnings results on Thursday, March, 28th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.03. The company had revenue of $346.86 million for the quarter, compared to analyst estimates of $309.80 million. P3 Health Partners had a negative trailing twelve-month return on equity of 120.85% and a negative net margin of 4.56%. What guidance has P3 Health Partners issued on next quarter's earnings? P3 Health Partners updated its FY 2024 earnings guidance on Thursday, March, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.4 billion. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PIII) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
